Qube Research & Technologies (QRT)
EVLO

Qube Research & Technologies (QRT)’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio EVLO Stock Details EVLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,477
Closed -$47.6K – 3157
2022
Q4 		$47.6K Buy
1,477
+493
+50% +$19.5K ﹤0.01% 2144
2022
Q3 		$41K Sell
984
-554
-36% -$25.3K ﹤0.01% 2181
2022
Q2 		$65K Buy
+1,538
New +$71.3K ﹤0.01% 2069
2020
Q4 		– Sell
-527
Closed -$56K – 2305
2020
Q3 		$56K Buy
+527
New +$48K ﹤0.01% 1538

Other funds holding EVLO

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $170M AUM 34.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Alphabet Inc
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Qube Research & Technologies (QRT)'s EVLO Position: Q1 2023 in Review

Qube Research & Technologies (QRT) sold out of Evelo Biosciences, Inc. Common Stock (EVLO) in Q1 2023, closing a stake of 1,477 shares — an estimated $47.6K sold.

Qube Research & Technologies (QRT) first reported a position in EVLO in Q3 2020 and held it in 4 quarters. The position peaked at $65K in Q2 2022. 39 funds tracked by Wall St. Rank hold EVLO as of Q1 2023.

  • Qube Research & Technologies (QRT) reported no remaining Evelo Biosciences, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 1,477 Evelo Biosciences, Inc. Common Stock shares in Q1 2023, an estimated $47.6K.
  • Qube Research & Technologies (QRT) first reported a position in Evelo Biosciences, Inc. Common Stock in Q3 2020 and held it in 4 quarters.
  • Qube Research & Technologies (QRT)'s Evelo Biosciences, Inc. Common Stock position peaked at $65K in Q2 2022.
  • 39 funds tracked by Wall St. Rank held Evelo Biosciences, Inc. Common Stock as of Q1 2023.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2023, filed 15 May 2023.